ibandronic acid

ibandronic acid
Clinical data
Trade names	Boniva, Bonviva, Bondronat, others
AHFS/Drugs.com	Monograph
License data	EU EMA: by INN; US DailyMed: Ibandronate_sodium; US FDA: Ibandronate_sodium;
Pregnancy; category	AU: B3;
Routes of; administration	By mouth, intravenous
ATC code	M05BA06 (WHO) ;
Legal status
Legal status	US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	0.6%
Protein binding	90.9 to 99.5%; (concentration-dependent)
Metabolism	Nil
Elimination half-life	10 to 60 hours
Excretion	Kidney
Identifiers
	IUPAC name Hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;
CAS Number	114084-78-5 ;
PubChem CID	60852;
IUPHAR/BPS	3059;
DrugBank	DB00710 ;
ChemSpider	54839 ;
UNII	UMD7G2653W;
KEGG	D08056 ; as salt: D04486 ;
ChEBI	CHEBI:93770;
ChEMBL	ChEMBL997 ;
PDB ligand	BFQ (PDBe, RCSB PDB);
Chemical and physical data
Formula	C9H23NO7P2
Molar mass	319.230523996 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=P(O)(O)C(O)(CCN(CCCCC)C)P(=O)(O)O;
	InChI InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17) ; Key:MPBVHIBUJCELCL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Angol

ibandronic acid (tsz. ibandronic acids)